BIOMEDITECH ApS: Financial statements 2016
CVR: 34707847
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
BIOMEDITECH ApS (CVR 34707847) has filed annual accounts for 2016. In 2016, the company reported a net result of DKK -31,246 compared with DKK 0 the year before. Equity in the 2016 report amounted to DKK 93,036. The solvency ratio was 99.2%.
- Profit/Loss
- DKK -31,246
- Equity
- DKK 93,036
- Total Assets
- DKK 93,754
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | - | -31 t. | 93 t. | - |
| 2015 | 0 | 0 | 0 | 124 t. | - |
| 2014 | 0 | 0 | 35 | 124 t. | - |
Official annual report
Find more companies like BIOMEDITECH ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
BIOMEDITECH ApS has published its annual report for 2015. Revenue came to DKK 0, and the net result was DKK 0.
About BIOMEDITECH ApS
BIOMEDITECH ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2012. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named DRUG TESTING EUROPE ApS. The management consists of Tobias Chalmer Stahl Rasmussen. The company is owned by Chalmer Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 106,895 and a net result of DKK -6,298 compared with DKK 290,046 the year before. Equity in the 2025 report amounted to DKK 877,884.